Phio Pharmaceuticals Corp. (PHIO)

NASDAQ

$0.94

$+0.05

(+5.26%)

Pre-Market

Phio Pharmaceuticals Corp. (PHIO) Live Price Chart

Last updated: ⁦2026-10-28 11:47:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Phio Pharmaceuticals Corp. (PHIO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.94, with a market capitalization of $9.88M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.81 to $4.19. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$9.88M
Open	$0.89
Day's High	$3,118.50
Day's Low	$0.81
Previous Close	$0.89
Volume	--
Average Volume	131.19K
P/E Ratio	--
52-Week High	$4.19
52-Week Low	$0.81
Dividend Yield	--
Earnings Date	--

Phio Pharmaceuticals Corp. (PHIO) Pre-Market Stock Price

Phio Pharmaceuticals Corp. (PHIO) is trading at $0.94 in pre-market trading as of 2026-10-28 11:14:00, up 5.48% ($0.05) from the previous close of $0.89

Pre-market trading shows how investors are pricing PHIO before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Phio Pharmaceuticals Corp. (PHIO) 7-Day Stock Price Change

Over the past seven days, Phio Pharmaceuticals Corp. (PHIO) moved from $0.87 to $0.94, representing a gain of 8.18% ($0.07).

The stock traded between $0.85 and $0.94 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 64.31 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

PHIO 52-Week Price Position

Position in Range: 3.8%

52W Low$0.81

52W High$4.19

PHIO is currently trading at $0.94, placing it 3.8% of the way from its 52-week low of $0.81 to its 52-week high of $4.19. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Phio Pharmaceuticals Corp. (PHIO)?

Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762 and PH-894. The group is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. It is committed to discovering and developing cancer treatments for patients by creating new pathways toward a cancer-free future. The Company operates with a single operating segment, the Clinical segment, and all assets are located in the United States.

Phio Pharmaceuticals Corp. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	6
Exchange	NASDAQ
Company Website	https://www.phiopharma.com

How to Buy Phio Pharmaceuticals Corp. (PHIO) Stock on MEXC

Eligible investors can buy real shares of Phio Pharmaceuticals Corp. (PHIO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for PHIO and Place Your Order

Open the RealStocks trading page and search for PHIO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Phio Pharmaceuticals Corp. (PHIO) stock price today?

Phio Pharmaceuticals Corp. (PHIO) is currently trading at $ 0.94, up 5.48% ($0.05) from the previous close of $ 0.89. Intraday prices update in real time during regular trading hours.

2.Is PHIO stock going up or down today?

As of 2026-10-28 11:14:00, PHIO is trading at $ 0.94, up 5.48% ($0.05) from its previous close of $ 0.89. The stock has traded between $ 0.81 and $ 3,118.50 during today’s regular session. Past price movements do not guarantee future results.

3.What is PHIO pre-market price?

As of 2026-10-28 11:14:00, PHIO is trading at $ 0.94 in pre-market trading, up 5.48% ($0.05) from the previous close of $ 0.89. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is PHIO after-hours price?

As of 2026-10-28 11:14:00, PHIO is trading at $ 0.89 in after-hours trading, down 0.02% ($0.00) from the regular-session close of $ 0.89. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is PHIO stock trading now?

PHIO trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does PHIO sit relative to its 52-week high and low?

Over the past 52 weeks, PHIO has traded between a low of $ 0.81 and a high of $ 4.19. At $ 0.94, the stock is positioned 3.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Phio Pharmaceuticals Corp. in?

Phio Pharmaceuticals Corp. (PHIO) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Phio Pharmaceuticals Corp.'s market capitalization and where is it listed?

Phio Pharmaceuticals Corp. is listed on the NASDAQ exchange with a market capitalization of $ 9.88M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is PHIO valued in terms of P/E ratio and EPS?

PHIO trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.11. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Phio Pharmaceuticals Corp. pay a dividend?

Phio Pharmaceuticals Corp. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.